ZMUni Compliance Centre

If you would like to gain a clearer and more comprehensive understanding of the management of cosmetic ingredients in China, we invite you to explore our previous article, Cosmetic Ingredients in China: Your Guide to the Latest Compliance Requirements. It provides helpful insights to build a solid foundation before diving into this topic.     From April 22 to 28, 2025, 7 new cosmetic ingredients were notified with the China National Medical Products Administration (NMPA). They include:   The technical requirements for the 7 new cosmetic ingredients mentioned above have not been disclosed, and they have not yet entered the safety monitoring period.  

  When querying overseas ingredient manufacturers and distributors about the requirements for exporting ingredients for cosmetic use in China, the most common response is "Yes, we've completed NMPA registration." However, what does NMPA registration truly entail, and what are the specific obligations for exporting cosmetic ingredients to China?   This article offers a practical and up-to-date overview of cosmetic ingredients regulatory requirements in China to help relevant stakeholders navigate regulatory challenges with confidence.   Regulatory Landscape: CSAR and Key Authorities   China's cosmetics market is regulated by the National Medical Products Administration (NMPA). On January 1, 2021, the Cosmetic Supervision and Administration Regulation (CSAR)

  To help overseas companies stay up to date with cosmetic ingredient trends in China, ZMUni Compliance Centre will publish a regular series on New Cosmetic Ingredient (NCI) notifications. We hope this provides valuable insights for ingredient suppliers and brands looking to enter the Chinese market.     From April 11 to 21, 2025, 2 new cosmetic ingredients were notified with the China National Medical Products Administration (NMPA). They include: Ingredient Name in CN Notification No. Notifier in CN 透明质酸水杨酸酯钠 202500035 华熙生物科技股份有限公司 N-乙酰基-丝氨酰-脯氨酰-缬氨酰-异亮氨酰-缬氨酰-脯氨酰胺 202500036 北京茂思商贸有限公司   The technical requirements for the 2 new cosmetic ingredients mentioned above have not been disclosed, and they have not

  The in-cosmetics Global 2025 exhibition was successfully held from April 8 to 10 at the RAI Amsterdam Convention Centre in the Netherlands. As one of the world's premier events for cosmetic and personal care ingredients, the show brought together over 1,000 exhibitors and thousands of visitors from across the globe. Each year, the event showcases the latest innovations in raw materials, formulations, and technologies, while serving as a vital platform for global exchange and collaboration within the beauty industry.   This year, nearly 150 Chinese companies participated, with 27% of them being first-time exhibitors—a strong reflection of China's growing influence

To help overseas companies stay up to date with cosmetic ingredient trends in China, ZMUni Compliance Centre will publish a regular series on New Cosmetic Ingredient (NCI) notifications. We hope this provides valuable insights for ingredient suppliers and brands looking to enter the Chinese market.     From April 1st to 10th, 2025, 4 new cosmetic ingredients were notified with the China National Medical Products Administration (NMPA). They include: Ingredient Name in CN&EN Notification No. Notifier in CN 乙酰基三肽-30 瓜氨酸 Acetyl Tripeptide 30 Citrulline 202500031 深圳市护家科技有限公司 红景天苷 Salidroside 202500032 上海华茂药业有限公司 昙花（Epiphyllum oxypetalum）愈伤组织提取物 Epiphyllum Oxypetalum Callus Extract 202500033 杭州拾光欣雅有限公司 苦丁茶（ILEX KUDINGCHA）叶提取物 ILEX KUDINGCHA Leaf Extract 202500034 广州袋鼠妈妈科技创新研究有限公司

      On April 10, 2025, China's National Institutes for Food and Drug Control (NIFDC) released the Information on the Use of Some Ingredients Included in the Index of International Cosmetic Safety Assessment Data, along with a corresponding Q&A.   Developed in response to industry needs, this document builds upon the Ingredient Usage Information of Marketed Products released by NIFDC on February 9, 2025. It focuses on ingredients listed in the Index of International Cosmetic Safety Assessment Data that are frequently used in registered or notified cosmetics in China, particularly those lacking definitive safety conclusions or subject to usage restrictions. The update

The global cosmetics regulatory environment continues to evolve. To help businesses stay updated with regulatory changes, ZMUni Compliance Center regularly releases a monthly recap of global cosmetics regulations. This article covers the regulatory developments related to cosmetics within China and globe in March 2025, with an emphasis on updates in cosmetic ingredient, cosmetic notification, labeling, etc.     China Cosmetic Regulatory Updates New Cosmetics Ingredients (NCI) Notification   In March 2025, 11 new cosmetic ingredients were notified with the China National Medical Products Administration (NMPA). They include: Ingredient Name in CN and EN Notification No. Notifier 铁皮石斛（DENDROBIUM OFFICINALE）培养物 20250020 沈阳科康科技有限公司 HDI/二 C12-14 醇酒石酸酯/氢化二聚亚油醇共聚物 Hdi/di-c12-14 Alkyl Tartrate/hydrogenated Dilinoleyl Alcohol Copolymer 20250021

  As of March 2025, 237 new cosmetic ingredients (NCIs) have been successfully notified in China, with one ingredient approved for registration. In Q1 2025, 30 NCIs were newly notified. With the implementation of new regulations in February, innovation in cosmetic ingredients is expected to accelerate, and the total number of notified NCIs in 2025 is likely to exceed 100.   Overview In Q1 2025, no new cosmetic ingredient (NCI) have been publicly registered yet, but the number of NCI notifications continues to rise. According to data from China’s National Medical Products Administration (NMPA), a total of 30 NCIs were notified this quarter,